Medical Safety Follow-up Study for Patients Who Received More Than 28 Days of Total Exposure to BGG492
Clinical trial NCT02150213 · COMPLETED
Trial details
- NCT number
- NCT02150213
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-08-01
- Primary completion
- 2015-09-01
- Enrollment
- 59
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.